Hello, Fool! | Login | Signup | My Fool
Dec 4, 2008 9:10 PM ET | Feedback | Site Changes | Help
Discovers, develops and intend to commercialize drugs for the treatment of neurological and endocrine-related diseases and disorders. Product candidates will target insomnia, anxiety, depression, cancer, diabetes, and multiple sclerosis.
View All Commentary (NBIX)
Recs
tharlow (44.85) Submitted: 8/11/07 4:35 PM : Start Price: $10.21 NBIX Score: -31.00
Drastically undervalued biotech with a deep pipeline of potential blockbusters.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK